Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.

about

Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.

Item

http://www.wikidata.org/entity/Q42668963

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Five-fraction SBRT for ultra-c ...... h-dose conventional radiation.

@en

Five-fraction SBRT for ultra-c ...... h-dose conventional radiation.

@nl

type

Item

label

Five-fraction SBRT for ultra-c ...... h-dose conventional radiation.

@en

Five-fraction SBRT for ultra-c ...... h-dose conventional radiation.

@nl

prefLabel

Five-fraction SBRT for ultra-c ...... h-dose conventional radiation.

@en

Five-fraction SBRT for ultra-c ...... h-dose conventional radiation.

@nl

P1476

Five-fraction SBRT for ultra-c ...... h-dose conventional radiation.

@en

P2093

Brian T Collins

http://www.w3.org/2001/XMLSchema#string

Eric Anderson

http://www.w3.org/2001/XMLSchema#string

Lloyd Campbell

http://www.w3.org/2001/XMLSchema#string

Michael C Repka

http://www.w3.org/2001/XMLSchema#string

Nima Aghdam

http://www.w3.org/2001/XMLSchema#string

Sean P Collins

http://www.w3.org/2001/XMLSchema#string

Shaan K Kataria

http://www.w3.org/2001/XMLSchema#string

Simeng Suy

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung.

Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and i(125) vicryl mesh brachytherapy.

P2888

s13014-017-0897-6

P304

162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-017-0897-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan W Lischalk

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092304076

http://www.w3.org/2001/XMLSchema#string

P698

29052514

http://www.w3.org/2001/XMLSchema#string

P932

5649069

http://www.w3.org/2001/XMLSchema#string